• Vt. to get $1.1 million drug settlement
    November 17,2012
    • Email Article
    •  
    •  Print Article
     
    MONTPELIER ó Vermontís attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandiaís cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.
    • Email Article
    •  
    •  Print Article
    2 Comments
    MORE IN Vermont News
    MONTPELIER ó Senate lawmakers gutted a bill intended to offer protections for landowners who want... Full Story
    INDIANAPOLIS ó Donald Trump virtually clinched the Republican nomination for president Tuesday... Full Story
    Cruz drops out; Sanders leads in Indiana
    MONTPELIER ó The Vermont House on Tuesday soundly rejected a Senate proposal to legalize... Full Story
    House kills marijuana legalization
    More Articles